futureTEKnow Company Profile

Chai Discovery

Chai Discovery builds an AI platform for de novo antibody design and molecule discovery for biologics research.

Headquarters

San Francisco, California, USA

Year Founded

2024

Impacted Industries

Biotechnology, pharmaceuticals, drug discovery, life sciences, computational biology, biomedical research

About Us

Chai Discovery builds frontier AI that predicts and reprograms biochemical interactions. Its platform supports de novo antibody design, molecular modeling, and biologics discovery, helping teams design novel therapeutic molecules with less trial-and-error.

Search Tags

AI drug discovery, antibody design, biologics discovery, molecular modeling, therapeutic design

Related Articles

Trending Companies

Latest Articles

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.